CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
Clinical trial NCT03118180 · UNKNOWN
Trial details
- NCT number
- NCT03118180
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2018-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.